The insulin‐like growth factor system and sarcomas
- 15 January 2009
- journal article
- review article
- Published by Wiley in The Journal of Pathology
- Vol. 217 (4) , 469-482
Abstract
Sarcomas are a diverse group of malignant mesenchymal tumours arising from bone and soft tissues. The identification of critical cellular signalling pathways in sarcomas is an important issue for the development of new targeted therapies. This review highlights the experimental and clinical evidence supporting the role of the insulin‐like growth factor (IGF) signalling system in the cellular transformation and progression of several types of sarcoma, including rhabdomyosarcoma, synovial sarcoma, leiomyosarcoma, Ewing's sarcoma and osteosarcoma. Preclinical data suggest that the IGF system could be a promising target for therapy in these sarcomas. Currently, therapies interrupting IGF signalling have been or are being developed. In recent phase 1 clinical studies with humanized monoclonal antibodies directed against IGF receptor type 1 (IGF‐1R), objective tumour responses were observed in several patients with Ewing's sarcoma, encouraging further clinical testing in Ewing's sarcoma and other sarcoma (sub)types. Moreover, the occasional occurrence of paraneoplastic hypoglycaemia as a result of the secretion of incompletely processed forms of pro‐IGF‐II by sarcomas is discussed. Copyright © 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
Funding Information
- Dutch Cancer Society
- The Netherlands Organization for Health Research and Development
This publication has 131 references indexed in Scilit:
- Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumorsProceedings of the National Academy of Sciences, 2008
- Differential roles of SS18–SSX fusion gene and insulin-like growth factor-1 receptor in synovial sarcoma cell growthBiochemical and Biophysical Research Communications, 2008
- Insulin-Like Growth Factor II Receptor-Mediated Intracellular Retention of Cathepsin B Is Essential for Transformation of Endothelial Cells by Kaposi's Sarcoma-Associated HerpesvirusJournal of Virology, 2007
- Analysis of Genes Critical for Growth Regulation Identifies Insulin-like Growth Factor 2 Receptor Variations with Possible Functional Significance as Risk Factors for OsteosarcomaCancer Epidemiology, Biomarkers & Prevention, 2007
- Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trialThe Lancet, 2004
- Insulin-like growth factors and neoplasiaNature Reviews Cancer, 2004
- Rhabdomyosarcoma – working out the pathwaysOncogene, 1999
- AP-2 may contribute to IGF-II overexpression in rhabdomyosarcomaOncogene, 1998
- Inhibition of Metastatic Behavior of Murine Osteosarcoma by HypophysectomyJNCI: Journal of the National Cancer Institute, 1992
- Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor.Journal of Clinical Investigation, 1990